The U.S. cannabis industry has seen billions of dollars of acquisitions in recent months, attracting scrutiny from federal trustbusters examining whether planned purchases could quash competition in the emerging marijuana industry. The U.S. Department of Justice’s review of the deals – including those involving Chicago-based Cresco Labs (CSE: CL; OTC: CRLBF) and Arizona-based Harvest Health & Recreation (CSE: HARV; OTC:
Antitrust issues weigh on US cannabis stocks, but is it enough to unravel deals? is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
[Read More ...]
additional information, George Scorsis
Originally posted on Antitrust issues weigh on US cannabis stocks, but is it enough to unravel deals? via George Scorsis Medical Marijuana News
No comments:
Post a Comment